Vaccines for the New Millennium Act of 2005
Legislative Progress
Introduced
September 14, 2005
Latest Action
September 14, 2005
Primary Sponsor
John F. KerryDemocratic(MA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2006 · year_end · Foreign Relations
HR 5674: Protections Against Transmission of HIV for Women and Youth (PATHWAY) Act S 3775: Sub-Saharan African Health Workforce Investment Act S.1698 and HR 3781: Vaccines for the New Millennium Act of 2005 HR 5522: FY 2007 Foreign Operations Appropriations - global health provisions HR 4188: Focus on Family Health Worldwide Act HR 4736: Ensuring Access to Contraceptives Act HR 4222 and S 2765: Child Health Investment for Long-term Development (CHILD and Newborn) Act
Client expense: $20,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · year_end · Medical/Disease Research/Clinical Labs
S. 950: Elimination of Neglected Diseases (END) Act of 2005 S. 492: Safe Water: Currency for Peace Act of 2005 S. 850: The Global Health Corps Act S. 2170: The Global Pathogens Surveillance Act of 2005 S. 1698: Vaccines for the New Millennium Act of 2005 S. 470: Fair Access to Clinical Trials Act of 2005 H.R. 3196: Fair Access to Clinical Trials Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
| Democratic |
| WA |
| Richard G. Lugar | Republican | IN |
| Richard J. Durbin | Democratic | IL |